Kate Bingham

Dame Catherine Elizabeth Bingham HonFMedSci (born 19 October 1965 ) is a British venture capitalist.

She is a managing partner at a venture capital firm, SV Health Investors.

Bingham worked in business development for Vertex Pharmaceuticals and consultants Monitor Company before joining Schroder Ventures in 1991 (now SV Health Investors).

She became a managing partner specializing in biotechnology, and has served on the boards of companies in the UK, US, Ireland, Sweden and Germany.

As of January 2021 she is listed as being a director of the following active companies: Mestag Therapeutics Ltd; Cybele Therapeutics Ltd; Bicycle tx Ltd; Bicycle Therapeutics plc; Sitryx Therapeutics Ltd; Pulmocide Ltd; Autifony Therapeutics Ltd; Bicycle RD Ltd; SV Health Investors Ltd (whose subsidiaries include the Dementia Discovery Fund); and SV Health Managers LLP.

She serves on the boards of the Francis Crick Institute and Aria.

Bingham married Jesse Norman in 1992; the couple have two sons and a daughter.

Norman is a Conservative Party politician and a member of Parliament since 2010, who has held various ministerial posts since 2016.

In January 2017 Bingham received the Lifetime Achievement Award of the BioIndustry Association UK.

She was appointed Dame Commander of the Order of the British Empire (DBE) in the 2021 Birthday Honours for "services to the procurement, manufacture and distribution of Covid-19 vaccines", Bingham was also admitted to the Freedom of the City of London in that year.

She was elected an Honorary Fellow of the Royal Society (FRS) in 2023 and was elected an Honorary Fellow of the Royal Academy of Engineering later the same year.

She is a Fellow of the Academy of Medical Sciences and holds honorary fellowships from the Faculty of Pharmaceutical Medicine and the British Pharmacological Society

Bingham has expressed views on how the UK covid vaccination programme could have been better run, and on how UK potential in life sciences could be improved.

She published her account of the seven months she spent chairing the Vaccine Taskforce in her book The Long Shot, in which she shared lessons for future pandemics and offered advice on how government can work more successfully with industry.

In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom.

Bingham was born in London, the only daughter of the barrister and judge Tom Bingham (later Lord Bingham of Cornhill) and Elizabeth ( Loxley) and the eldest of their three children.

She attended St Paul's Girls' School, London, before going on to study at the University of Oxford where she was an undergraduate student of Christ Church, Oxford, where she graduated with a first-class degree in Biochemistry (MA).

Bingham then pursued further studies at Harvard Business School, taking the degree of MBA.

She has an Honorary doctorate degree from Imperial College, London.

In May 2020 Bingham was appointed Chair of the UK Vaccine Taskforce, without a recruitment process.

The Taskforce was set up to manage the path towards the introduction of a COVID-19 vaccine in the UK and its global distribution.

In this temporary unpaid role, which finished at the end of the year, she reported to the prime minister.

In October, she was one of the participants in a trial of a vaccine by Novavax.

According to leaked documents seen by The Sunday Times, Bingham charged taxpayers £670,000 for a team of eight full-time boutique consultants from London PR agency Admiral Associates.

This report was later discredited.

Dame Kate's account of the risks, criticism and political interference she faced are discussed in her book The Long Shot which was published in October 2022 with all proceeds to the New Model Institute for Technology and Engineering (NMITE).

In this she detailed the need for a specialist health communications capability to launch a national Vaccines Registry which was a core part of the vaccine procurement and development strategy and that this was contracted by the Department of Business Energy and Industrial Strategy.

Dame Kate's work on the UK's vaccination rollout programme has been praised by scientists and international media, particularly for securing 350 million doses of six vaccines and setting up infrastructure for clinical trials, manufacturing and distribution.